{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:46:07Z","timestamp":1791351967971,"version":"4.3.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.neuroscience.2008.02.051","type":"journal-article","created":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T19:48:41Z","timestamp":1204919321000},"page":"679-686","source":"Crossref","is-referenced-by-count":52,"title":["High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice"],"prefix":"10.1016","volume":"153","author":[{"given":"F.","family":"Go\u00f1i","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Prelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Scholtzova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kascsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Chabalgoity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Wisniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2008.02.051_bib1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri1437","article-title":"Antiprion immunotherapy: to suppress or to stimulate?","volume":"4","author":"Aguzzi","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1126\/science.1122864","article-title":"Prions in skeletal muscles of deer with chronic wasting disease","volume":"311","author":"Angers","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2003.08.036","article-title":"Generation of antibodies against prion protein in wild-type mice via helix 1 peptide immunization","volume":"144","author":"Arbel","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/clim.2000.4875","article-title":"Prion diseases and the immune system","volume":"96","author":"Aucouturier","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1172\/JCI200113155","article-title":"Infected dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie","volume":"108","author":"Aucouturier","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib6","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.vaccine.2005.12.051","article-title":"Intranasal immunization of Balb\/c mice against prion protein attenuates orally acquired transmissible spongiform encephalopathy","volume":"24","author":"Bade","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1742-4658.2007.05631.x","article-title":"The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies","volume":"274","author":"Beekes","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3201\/eid1006.031082","article-title":"Chronic wasting disease and potential transmission to humans","volume":"10","author":"Belay","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/1097-0029(20000701)50:1<40::AID-JEMT7>3.0.CO;2-M","article-title":"Detection of PrP in extraneural tissues","volume":"50","author":"Brown","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1192\/bjp.bp.106.021832","article-title":"Prion diseases in humans: an update","volume":"189","author":"Butler","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000149503","article-title":"Preclinical changes in weight of scrapie-infected mice as a function of scrapie agent-mouse strain combination","volume":"27","author":"Carp","year":"1984","journal-title":"Intervirology"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0264-410X(00)00197-3","article-title":"A dog-adapted Salmonella typhimurium strain as a basis for a live oral Echinococcus granulosus vaccine","volume":"19","author":"Chabalgoity","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib13","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0140-6736(06)68930-7","article-title":"Kuru in the 21st century: an acquired human prion disease with very long incubation periods","volume":"367","author":"Collinge","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib14","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1073\/pnas.151242598","article-title":"Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody","volume":"98","author":"Enari","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib15","doi-asserted-by":"crossref","first-page":"18524","DOI":"10.1074\/jbc.M210723200","article-title":"Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells","volume":"278","author":"Gilch","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.neuroscience.2005.02.031","article-title":"Mucosal vaccination delays or prevents prion infection via an oral route","volume":"133","author":"Goni","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/path.2104","article-title":"Immunosenescence of ageing","volume":"211","author":"Gruver","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib18","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1742-4658.2007.05721.x","article-title":"Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells","volume":"274","author":"Handisurya","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/science.1063093","article-title":"Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies","volume":"294","author":"Heppner","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.vaccine.2006.09.078","article-title":"Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion","volume":"25","author":"Ishibashi","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0168-1702(89)90039-7","article-title":"The role of the spleen in the neuroinvasion of scrapie in mice","volume":"12","author":"Kimberlin","year":"1989","journal-title":"Virus Res"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vaccine.2005.08.008","article-title":"Evaluation of Salmonella enterica serovar typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers","volume":"24","author":"Kirkpatrick","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-065X.1997.tb01032.x","article-title":"Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development","volume":"160","author":"LeMaoult","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s004010100417","article-title":"Deposition patterns of disease-associated prion protein in captive mule deer brains with chronic wasting disease","volume":"102","author":"Liberski","year":"2001","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrmicro1346","article-title":"Prions and their lethal journey to the brain","volume":"4","author":"Mabbott","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2007.01.005","article-title":"Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice","volume":"53","author":"Mallucci","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib27","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1042\/BST0341155","article-title":"The transmissible spongiform encephalopathies: emerging and declining epidemics","volume":"34","author":"Manson","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib28","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1073\/pnas.95.5.2520","article-title":"Vaccination with an attenuated Creutzfeldt-Jakob disease strain prevents expression of a virulent agent","volume":"95","author":"Manuelidis","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib29","doi-asserted-by":"crossref","first-page":"13794","DOI":"10.1128\/JVI.79.21.13794-13796.2005","article-title":"Interspecies transmission of chronic wasting disease prions to squirrel monkeys (Saimiri sciureus)","volume":"79","author":"Marsh","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/tvjl.2000.0502","article-title":"Salmonella: immune responses and vaccines","volume":"161","author":"Mastroeni","year":"2001","journal-title":"Vet J"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1126\/science.1132661","article-title":"Infectious prions in the saliva and blood of deer with chronic wasting disease","volume":"314","author":"Mathiason","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib33","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/JVI.79.7.4033-4042.2005","article-title":"Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP","volume":"79","author":"Nikles","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib34","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/j.1460-9568.2006.04805.x","article-title":"Clearance and prevention of prion infection in cell culture by anti-PrP antibodies","volume":"24","author":"Pankiewicz","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib35","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35089090","article-title":"Antibodies inhibit prion propagation and clear cell cultures of prion infectivity","volume":"412","author":"Peretz","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib36","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.0404772101","article-title":"Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection","volume":"101","author":"Polymenidou","year":"2004","journal-title":"Proc Natl Acad Sca U S A"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib37","series-title":"Neurology in clinical practice","first-page":"1567","article-title":"Infectious disease of the nervous system: prion diseases","author":"Sadowski","year":"2008"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/14760584.6.1.75","article-title":"Recent developments in mucosal vaccines against prion diseases","volume":"6","author":"Sakaguchi","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/1389557053544065","article-title":"Therapeutics and prion disease: can immunization or drugs be effective?","volume":"5","author":"Sasson","year":"2005","journal-title":"Mini-Rev Med Chem"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib40","doi-asserted-by":"crossref","first-page":"46199","DOI":"10.1074\/jbc.C300303200","article-title":"Copper chelation delays the onset of prion disease","volume":"278","author":"Sigurdsson","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3940(02)01192-8","article-title":"Anti-PrP antibodies for prophylaxis following prion exposure in mice","volume":"336","author":"Sigurdsson","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9440(10)64151-X","article-title":"Vaccination delays the onset of prion disease in mice","volume":"161","author":"Sigurdsson","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1586\/14760584.4.5.607","article-title":"Promising developments in prion immunotherapy","volume":"4","author":"Sigurdsson","year":"2005","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib44","first-page":"161","article-title":"The epidemiology of variant Creutzfeldt-Jakob disease","volume":"284","author":"Smith","year":"2004","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib45","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/1521-4141(200108)31:8<2338::AID-IMMU2338>3.0.CO;2-V","article-title":"Modulation of proteinase-K resistant prion protein by prion peptide immunization","volume":"31","author":"Souan","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib46","first-page":"36","article-title":"CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils","volume":"14","author":"Spinner","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib47","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.68.3.1196-1201.2000","article-title":"Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers","volume":"68","author":"Tacket","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib48","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1128\/JVI.00098-06","article-title":"Transmission of elk and deer prions to transgenic mice","volume":"80","author":"Tamguney","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib49","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/brain\/awl150","article-title":"A systematic review of prion therapeutics in experimental models","volume":"129","author":"Trevitt","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0264-410X(97)00156-4","article-title":"Immune responses in calves immunised orally or subcutaneously with a live Salmonella typhimurium aro vaccine","volume":"16","author":"Villarreal-Ramos","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nature01457","article-title":"Monoclonal antibodies inhibit prion replication and delay the development of prion disease","volume":"422","author":"White","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib52","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1354\/vp.42-5-530","article-title":"Chronic wasting disease","volume":"42","author":"Williams","year":"2005","journal-title":"Vet Pathol"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib53","doi-asserted-by":"crossref","first-page":"243","DOI":"10.20506\/rst.26.1.1739","article-title":"Is vaccination against transmissible spongiform encephalopathies feasible?","volume":"26","author":"Wisniewski","year":"2007","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.neuroscience.2008.02.051_bib54","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1111\/j.1742-4658.2007.05919.x","article-title":"Therapeutic approaches for prion and Alzheimer's diseases","volume":"274","author":"Wisniewski","year":"2007","journal-title":"FEBS J"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452208002996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452208002996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T21:07:03Z","timestamp":1588453623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452208002996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0306452208002996"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2008.02.051","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}